Evaluation of a novel autoinjector for subcutaneous self-administration of belimumab in systemic lupus erythematosus

Objective: To study self-administration and pharmacokinetics (PK) of subcutaneous (SC) belimumab in patients with systemic lupus erythematosus (SLE). Methods: Patients previously treated with belimumab self-administered belimumab 200 mg SC weekly for 8 weeks using an autoinjector. The primary endpoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheikh, Saira Z., Hammer, Anne E., Fox, Norma Lynn, Groark, James, Struemper, Herbert, Roth, David, Gordon, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100660/
https://www.ncbi.nlm.nih.gov/pubmed/27668697
http://dx.doi.org/10.5414/CP202623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100660/
https://www.ncbi.nlm.nih.gov/pubmed/27668697
http://dx.doi.org/10.5414/CP202623

Ejemplares similares